New Pharm Exec Europe supplement explores how sales reps' thinking and behaviour can really be changed.
The articles by IMS's Kevin Dolgin in Pharm Exec Europe'slatest supplement are very much concerned with the best kind of training that is, training that works, and achieves the desired goal of affecting a real behavioural change in the sales force. Kevin investigates the methodologies that lie behind successful training programmes, and, importantly, also looks beyond the methodologies to the management support that is necessary to sustain the lessons learned and to facilitate the new practices. And, as he perceptively observes, the power of conforming to peer group behaviour should not be underestimated: the more we start to think and do things differently after training, the more our colleagues will follow.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.